We used CRISPR/Cas9 to knock out ZNF793 in the ZNF793-expressing GC cell lines SNU719 and AGS and verified the results via RT‒PCR and Western blotting (Fig. 2d & e). Here, ZNF793 is linked to gastric cancer.